Abstract:ABSTRACT Vaccination is important to prevent cholera. There are limited data comparing anti-O-specific polysaccharide (OSP) and anti-cholera toxin-specific immune responses following oral whole-cell with cholera toxin B-subunit (WC-rBS) vaccine (Dukoral, Valneva) administration in different age groups. An understanding of the differences is relevant because young children are less well protected by oral cholera vaccines than older children and adults. We compared responses in 50 adults and 49 children (ages 2 to <18) who were administered two doses of WC-rBS at a standard 14-day interval. All age groups had significant IgA and IgG plasma-blast responses to the OSP and cholera toxin B-subunit (CtxB) antigens that peaked 7 days after vaccination. However, in adults and older children (ages 5 to <18), antibody responses directed at the OSP antigen were largely IgA and IgG, with a minimal IgM response, while younger children (ages 2 to <5) mounted significant increases in IgM with minimal increases in IgA and IgG antibody responses 30 days after vaccination. In adults, anti-OSP and CtxB memory B-cell responses were detected after completion of the vaccination series, while children only mounted CtxB-specific IgG memory B-cell responses and no OSP-memory B-cell responses. In summary, children and adults living in a cholera endemic area mounted different responses to the WC-rBS vaccine, which may be a result of more prior exposure to Vibrio cholerae in older participants. The absence of class-switched antibody responses and memory B-cell responses to OSP may explain why protection wanes more rapidly after vaccination in young children compared to older vaccinees. IMPORTANCE Vaccination is an important strategy to prevent cholera. Though immune responses targeting the OSP of V. cholerae are believed to mediate protection against cholera, there are limited data on anti-OSP responses after vaccination in different age groups, which is important as young children are not well protected by current oral cholera vaccines. In this study, we found that adults mounted memory B-cell responses to OSP, which were not seen in children. Adults and older children mounted class-switched (IgG and IgA) serum antibody responses to OSP, which were not seen in young children who had only IgM responses to OSP. The lack of class-switched antibody responses and memory B-cell responses to OSP in younger participants may be due to lack of prior exposure to V. cholerae and could explain why protection wanes more rapidly after vaccination in young children.

What problem does this paper attempt to address?

The paper attempts to address the differences in O-specific polysaccharide (OSP) and cholera toxin-specific immune responses induced by the oral cholera vaccine (Dukoral) among different age groups. Specifically, the study aims to compare the immune responses of adults, older children (5 to under 18 years), and younger children (2 to under 5 years) after receiving two doses of the Dukoral vaccine to understand why younger children have poorer and shorter-lasting protection from the oral cholera vaccine. ### Main Issues: 1. **Age Differences in Immune Response**: The study investigates whether there are significant differences in the immune responses to OSP and cholera toxin B subunit (CtxB) among different age groups after receiving the Dukoral vaccine. 2. **Duration of Protective Effect**: The study seeks to explain why younger children have less durable protection after vaccination compared to adults and older children. 3. **Generation of Memory B Cells**: The study evaluates whether different age groups can generate memory B cells specific to OSP after vaccination and the relationship between the generation of these memory B cells and the protective effect. ### Research Background: - **Importance of Cholera Vaccine**: Cholera is an acute diarrheal disease caused by Vibrio cholerae, and oral cholera vaccines (OCVs) are currently recommended for use in endemic and epidemic areas to prevent the disease. - **Role of OSP and CtxB**: OSP is the major antigenic determinant of Vibrio cholerae lipopolysaccharide, and the immune response to OSP plays a crucial role in protective immunity. CtxB is the B subunit of cholera toxin and is also an important antigenic component. - **Immune Response in Young Children**: The poorer protection in young children from cholera vaccines may be due to their weaker initial immune response to the OSP antigen and a lack of systemic response capability. ### Research Methods: - **Participants**: The study included 99 healthy volunteers, comprising 50 adults and 49 children (2 to under 18 years), with children further divided into older children (5 to under 18 years) and younger children (2 to under 5 years). - **Vaccination**: All participants received two doses of the Dukoral vaccine on days 0 and 14. - **Sample Collection**: Blood samples were collected on days -14, 2, 7, and 44 post-vaccination to measure levels of vibriocidal antibodies, OSP and CtxB-specific antibodies, and circulating antibody-secreting cells (ASCs) and memory B cells (MBCs). ### Main Findings: - **Adults and Older Children**: After vaccination, adults and older children produced significant IgA and IgG antibody responses to OSP and CtxB, and memory B cells specific to OSP were detected on day 44 post-vaccination. - **Younger Children**: Younger children primarily produced IgM antibody responses after vaccination and failed to generate memory B cells specific to OSP. Although they also produced IgG antibody responses to CtxB, the response was weaker. - **Differences in Immune Response**: These differences may explain why younger children have less durable protection after vaccination compared to adults and older children. ### Conclusion: - **Impact of Age on Immune Response**: The study results indicate that age significantly affects the immune response to the oral cholera vaccine, particularly the response to OSP. Adults and older children can generate more durable protective immunity, whereas younger children lack this capability. - **Mechanism Exploration**: The lack of memory B cell generation specific to OSP in younger children may be due to their limited prior exposure to Vibrio cholerae, leading to a weaker initial immune response. Additionally, the adaptive immune system in younger children is not fully mature, which may also affect their immune response. These findings provide important insights for optimizing the use of cholera vaccines in young children, helping to improve vaccine protection in this high-risk group.

Cholera toxin and O-specific polysaccharide immune responses after oral cholera vaccination with Dukoral in different age groups of Bangladeshi participants

Induction of systemic, mucosal and memory antibody responses targeting Vibrio cholerae O1 O-specific polysaccharide (OSP) in adults following oral vaccination with an oral killed whole cell cholera vaccine in Bangladesh

Comparison of O-specific polysaccharide responses in patients following infection with Vibrio cholerae O139 versus vaccination with a bivalent (O1/O139) oral killed cholera vaccine in Bangladesh

Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers

Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection among household contacts of cholera patients in Bangladesh

Kinetics of antibody-secreting cell and fecal IgA responses after oral cholera vaccination in different age groups in a cholera endemic country

A Cholera Conjugate Vaccine Containing O-specific Polysaccharide (OSP) of V. cholerae O1 Inaba and Recombinant Fragment of Tetanus Toxin Heavy Chain (OSP:rTTHc) Induces Serum, Memory and Lamina Proprial Responses against OSP and Is Protective in Mice

Evaluation in Mice of a Conjugate Vaccine for Cholera Made from Vibrio cholerae O1 (Ogawa) O-Specific Polysaccharide

Immunogenicity of a Killed Bivalent (O1 and O139) Whole Cell Oral Cholera Vaccine, Shanchol, in Haiti

Parenteral Vaccination with a Cholera Conjugate Vaccine Boosts Vibriocidal and Anti-OSP Responses in Mice Previously Immunized with an Oral Cholera Vaccine

Defining Polysaccharide-Specific Antibody Targets against <named-content content-type='genus-species'>Vibrio cholerae</named-content> O139 in Humans following O139 Cholera and following Vaccination with a Commercial Bivalent Oral Cholera Vaccine, and Evaluation of Conjugate Vaccines Targeting O139

Vibriocidal Antibody Responses to a Bivalent Killed Whole-Cell Oral Cholera Vaccine in a Phase III Trial in Kolkata, India

Plasma and Mucosal Immunoglobulin M, Immunoglobulin A, and Immunoglobulin G Responses to the Vibrio cholerae O1 Protein Immunome in Adults With Cholera in Bangladesh

Scalable production and immunogenicity of a cholera conjugate vaccine

Co-administration of Oral Cholera Vaccine with Oral Polio Vaccine among Bangladeshi Young Children: A Randomized Controlled Open Label Trial to Assess Interference

Systemic, Mucosal, and Memory Immune Responses following Cholera

Biomarkers of Environmental Enteropathy are Positively Associated with Immune Responses to an Oral Cholera Vaccine in Bangladeshi Children

Use of oral cholera vaccine as a vaccine probe to determine the burden of culture-negative cholera

Limited O-specific polysaccharide (OSP)-specific functional antibody responses in young children with Shigella infection in Bangladesh

Oral cholera vaccines containing B-subunit-killed whole cells and killed whole cells only. II. Field evaluation of cross-protection against other members of the Vibrionaceae family